您的账号已在其他设备登录,您当前账号已强迫下线,
如非您本人操作,建议您在会员中心进行密码修改

确定

A framework to investigate drug release variability arising from hypromellose viscosity specifications in controlled release matrix tablets.

摘要:

Substitution level, particle size, and molecular weight are key properties of hypromellose (HPMC) known to be important to its performance in pharmaceutical-controlled release applications. The hypromellose monographs indirectly specify acceptable ranges for the molecular weight of HPMC products, expressed as the apparent viscosity of a 2% aqueous solution. The purpose of this study was to provide a framework to systematically investigate the amount of drug release variability that might be expected for typical controlled release formulations over the monograph viscosity ranges for hypromellose. An approach to estimate the expected drug release variability was developed based on scaling laws in the literature. New experimental data were generated with pentoxifylline, theophylline, and hydrochlorothiazide as model drugs to explore the applicability of this approach to a range of formulations. This methodology predicted that drug release variability over the United States Pharmacopeia (USP) viscosity ranges would be greatest for the lower viscosity grades of hypromellose, such as E50 and K100 LV. Drug release variability due to hypromellose viscosity variations is expected to be larger for formulations having substantial contributions from erosional drug release, and smaller for formulations with a predominantly diffusional drug release mechanism. These predictions need to be validated experimentally. (c) 2007 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 97:2276-2284, 2008.

更多
作者: Mitchell,SA [1] ; Balwinski,KM [2]
作者单位: Water Soluble Polymers, The Dow Chemical Company, Midland, Michigan 48674. [1] Department of Obstetrics and Gynecology, University of New Mexico Health Sciences Center [2]
发布时间: 2013-01-01
翻译满意度评价:
提交
  • 浏览:40

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!